logo

For the Inventor, By the Inventor

North Brunswick, NJ, United States of America

Josephine R Carlin

This inventor holds 5 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josephine R Carlin. Retrieved from https://idiyas.com/inventor/josephine-r-carlin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 84(Granted Patents)


Location History:

  • North Brunswick, NJ (US) (1989 - 1993)
  • New Brunswick, NJ (US) (1997)
  • Annandale, NJ (US) (1998)

Company Filing History:

goldMedal5 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1989-1998

Loading Chart...
5 patents (USPTO):Explore Patents
1. 5843953 - 7-substituted 4-aza cholanic acid derivatives and their use (1998-12-01),
2. 5595996 - 7-substituted 4-aza cholanic acid derivatives and their use (1997-01-21),
3. 5215894 - Biological process for producing 17.beta.-N-monosubstituted (1993-06-01),
4. 4963667 - Ivermectin derivative compounds and process for preparing the same (1990-10-16),
5. 4845104 - Oxidized analogs of (1989-07-04),

Title: Josephine R Carlin: Innovator in Pharmaceutical Chemistry

Introduction

Josephine R Carlin is a prominent inventor based in North Brunswick, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that serve as 5.alpha.-reductase type 1 inhibitors. With a total of 5 patents to her name, her work has the potential to impact treatments for conditions associated with an excess of DHT.

Latest Patents

Among her latest patents is the innovative work on 7-substituted 4-aza cholanic acid derivatives and their use. These compounds are characterized by a specific formula that includes various substituents, such as R.sup.1, R.sup.2, R.sup.3, and R.sup.4, which can take on different chemical forms. The compounds described in her patents may be utilized for treating conditions linked to DHT excess, either alone or in combination with other 5.alpha.-reductase inhibitors.

Career Highlights

Josephine R Carlin is currently associated with Merck & Company, Inc., where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options in the pharmaceutical industry.

Collaborations

Throughout her career, Josephine has collaborated with notable colleagues, including Shuet-Hing Lee Chiu and Donald W Graham. These partnerships have contributed to the success and innovation of her projects.

Conclusion

Josephine R Carlin stands out as a significant figure in pharmaceutical innovation, with her patents paving the way for new treatments in healthcare. Her contributions reflect the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…